Tumor Ablation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
Transparency Market Research presents this most up-to-date research on "Tumor Ablation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024" Tumor ablation is a treatment that destroys cancerous tumors without removing them. This is done using a probe that utilizes thermal energy to heat or cool tumorigenic tissue to cytotoxic levels. Techniques such as computed tomography (CT), ultrasound (US), and magnetic resonance imaging (MRI) are used to guide and position the needle probe into the tumor. Tumor ablative techniques are used in patients having few tumors which are small in size. Ablation is best used for tumors no larger than an inch. For slightly larger tumors, ablation could be used along with embolization. Moreover, surgery for tumor removal is not a feasible treatment option for certain patients often due to poor health or reduced immunity, or reduced organ function. For such cases, tumor ablation is the preferred form of treatment prescribed. Tumor ablation treatment is also highly useful in patients who are awaiting liver transplant. Rise in cancer incidence coupled with growing preference for minimally invasive treatment options is anticipated to drive the tumor ablation market during the forecast period. However, the size of tumor treatable with this technique remains a challenge. Utilization of combination therapies to ameliorate this challenge shall further propel the market during the forecast period. Technological advancements pertaining to ablation devices is also likely to boost growth of the tumor ablation devices market. High cost of certain tumor ablation techniques such as cryoablation is likely to restrain the market during the forecast period. The tumor ablation market has been segmented based on type of modality, application, end-user, and region. In terms of type of modality, the market has been segmented into radiofrequency ablation, laser ablation, microwave ablation, and cryoablation. Radiofrequency ablation (RFA) is the percutaneous ablative modality most commonly used for tumor ablation in developed regions of the world. Hence, the radiofrequency ablation segment is anticipated to capture a significant share of the tumor ablation market during the forecast period. Cryoablation, although expensive, is a relatively painless procedure, which enables treatment of fragile patients who are not in a position to tolerate anesthesia. Based on application, the market has been segmented into liver cancer, lung cancer, breast cancer, prostate cancer, bone cancer, kidney cancer, and other cancers. The liver cancer segment is anticipated to account for significant share of the tumor ablation market in terms of revenue owing to its preference as a mode of treatment for liver cancer patients. Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/tumor-ablation-market.html